invokana lawyer

Tag Archive

What You Should Know About Fournier’s Gangrene

What You Should Know About Fournier’s Gangrene

| Pharmaceutical Litigation
The U.S. Food and Drug Administration (FDA) issued a warning in late August 2018 about the link between diabetic medications and a rare, yet life-threatening disease called Fournier’s gangrene. The warning is specific to certain FDA-approved inhibitors (SGLT2), which are said to prevent the kidneys from reabsorbing sugar into the blood, therefore helping lower blood…Read the article
Invokana and Fournier’s Gangrene

Invokana and Fournier’s Gangrene

| Pharmaceutical Litigation
When you take a medication prescribed to you by your health care provider to treat a condition, you usually expect some side effects. You usually do not think about the medication killing you faster and in a more painful way than the condition you are trying to treat. However, for some unlucky souls taking Invokana,…Read the article
Health Risks and Concerns With Invokana

Health Risks and Concerns With Invokana

| Pharmaceutical Litigation
Invokana, medically known by the drug name canagliflozin, is a sodium-glucose co-transporter 2 inhibitor and is being prescribed to help control blood sugar in people with Type 2 Diabetes. It is used as part of a treatment plan and is used in addition to diet and exercise when results are not being seen and levels are…Read the article
Invokana & Kidney Failure

Invokana & Kidney Failure

| Pharmaceutical Litigation
Type II diabetes is a life-threatening disease, and as such, those who suffer from type II diabetes often turn to medication for help in treating the illness. One such prescription medication is Invokana (canagliflozin), which helps to lower blood sugar by forcing the kidneys to remove sugar through urination. However, in June 2016, the FDA…Read the article
Hunter Shkolnik on Invokana Plaintiff Executive Committee

Hunter Shkolnik on Invokana Plaintiff Executive Committee

| Napoli Shkolnik News
The firm is representing many victims who were prescribed Invokana. We are proud to announce that Partner Hunter J. Shkolnik has been named as a Plaintiffs’ Executive Committee Member in In Re: Invokana (Canagliflozin) Products Liability Litigation (MDL No. 2750) United Stated District Judge Brian R. Martinotti of the United States District Court of New…Read the article
Drug Safety Communication Alert

Drug Safety Communication Alert

| Pharmaceutical Litigation
Napoli Shkolnik PLLC has learned that the Federal Drug Administration (FDA) has issued an alert for the patients of diabetes drugs Invokana and Invokamet. As part of ongoing clinical trials, the interim safety results have found an increase in leg and foot amputations, mostly affecting the toes, in patients being treated with the diabetes medication…Read the article
The Deadly Side of Prescription Drugs

The Deadly Side of Prescription Drugs

| Pharmaceutical Litigation
Many people are not aware that medical malpractice, the mistakes made by healthcare professionals in hospitals around the country, is responsible for the premature deaths of between 210,000 to 440,000 Americans every year, according to the Journal of Patient Safety. When contemplating this immense number, which is at least three times larger than all gun…Read the article
GET HELP NOW